Lessee, Operating Lease, Liability, Undiscounted Excess Amount of U S PHYSICAL THERAPY INC /NV from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
U S PHYSICAL THERAPY INC /NV quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • U S PHYSICAL THERAPY INC /NV Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 31 Dec 2025 was $19,376,000, a 22% increase year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

U S PHYSICAL THERAPY INC /NV Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $19,376,000 +$3,431,000 +22% 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q3 2025 $17,738,000 +$7,592,000 +75% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $17,219,000 +$7,093,000 +70% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $16,087,000 +$6,833,000 +74% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $15,945,000 +$7,119,000 +81% 31 Dec 2024 10-K 03 Mar 2025 2024 FY
Q3 2024 $10,146,000 +$1,701,000 +20% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $10,126,000 +$2,354,000 +30% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $9,254,000 +$2,364,000 +34% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $8,826,000 +$2,049,000 +30% 31 Dec 2023 10-K 29 Feb 2024 2023 FY
Q3 2023 $8,445,000 +$2,138,000 +34% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $7,772,000 +$1,977,000 +34% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $6,890,000 +$1,162,000 +20% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $6,777,000 +$602,000 +9.7% 31 Dec 2022 10-K 28 Feb 2023 2022 FY
Q3 2022 $6,307,000 +$213,000 +3.5% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $5,795,000 -$130,000 -2.2% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $5,728,000 +$176,000 +3.2% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $6,175,000 +$424,000 +7.4% 31 Dec 2021 10-K 01 Mar 2022 2021 FY
Q3 2021 $6,094,000 +$268,000 +4.6% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $5,925,000 -$434,000 -6.8% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $5,552,000 -$2,171,000 -28% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $5,751,000 -$1,302,000 -18% 31 Dec 2020 10-K 01 Mar 2021 2020 FY
Q3 2020 $5,826,000 -$1,109,000 -16% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $6,359,000 -$140,000 -2.2% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $7,723,000 +$1,662,000 +27% 31 Mar 2020 10-Q 21 May 2020 2020 Q1
Q4 2019 $7,053,000 31 Dec 2019 10-K 28 Feb 2020 2019 FY
Q3 2019 $6,935,000 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $6,499,000 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $6,061,000 31 Mar 2019 10-Q 06 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.